Shares of Medline, which sells medical products such as ECG/EKG machines and post-operation bandages, were up more than 31% in afternoon trade above 38. The Nasdaq-listed stock opened nearly 21% above its IPO price of $29 a share, which marked $6.26 billion raised by the company.

This year marked the exchange’s highest volume for capital raised since 2021, $46.65 billion from new listings, extending a decade of leadership in U.S. listings and underscoring Nasdaq’s role as the home to many of the world’s most ambitious and innovative companies.

Blue Gold Limited (Nasdaq: BGL), a vertically integrated gold fintech company, today announced that an updated independent analyst report has set a revised price target of up to $22 per share. The adjustment reflects renewed institutional interest in companies combining traditional commodities with digital financial solutions.

US stocks experienced a downturn as investors shifted away from AI giants. Concerns over Oracle's data center financing, coupled with broader questions about AI profitability, triggered a sell-off. Major tech stocks like Nvidia and AMD also saw significant declines,

U.S. Securities and Exchange Commission Chairman Paul S. Atkins joined Nasdaq Chair and CEO Adena Friedman on Tuesday, December 2 nd, 2025, to celebrate 250 years of the United States and to chart a course for the future of American economic growth ...

Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has been notified by Nasdaq that the company’s stock is expected to be added to the Nasdaq Biotech Index (NASDAQ: NBI) as part of the annual reconstitution of the 2025 Nasdaq indexes.

Nasdaq has filed a rule change with the Securities and Exchange Commission (SEC) to extend trading in U.S.-listed stocks and exchange-traded products to 23 hours a day, five days a week. Today, Nasdaq effectively runs a 16-hour schedule,

About This EventThe National Kidney Foundation celebrates 75 years of making a significant impact in the fight against kidney disease today at the Nasdaq MarketSite in Times Square.The non-profit organization is focused on eliminating preventable kidney disease,